Trial
NCT01801163
A Phase Ib Study of Stereotactic Body Radiotherapy (SBRT) Plus Sorafenib in Patients With Unresectable Hepatocellular Carcinoma (HCC)
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Indiana University
Collaborators
—
Condition
Hepatocellular Carcinoma
Intervention
Sorafenib
Why stopped
Trial had no patients accrued while open
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-04-16